Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABB
801
DELISTED
ABB Ltd
ABB
| $10.6M | 0.02% |
461,900
-326,700
| -41% | -$7.91M |
|
|
DDC
802
DELISTED
Dominion Diamond Corporation
DDC
| $10.6M | 0.02% |
734,228
-165,870
| -18% | -$2.16M |
|
|
SONC
803
DELISTED
Sonic Corp
SONC
| $10.6M | 0.02% |
479,000
-419,700
| -47% | -$8.86M |
|
|
QEP
804
DELISTED
QEP RESOURCES, INC.
QEP
| $10.6M | 0.02% |
306,225
+209,900
| +218% | +$6.64M |
|
805
SunCoke Energy
SXC
$788M
| $10.6M | 0.02% |
490,900
-201,000
| -29% | -$4.22M |
|
806
DuPont de Nemours
DD
$19.5B
| $10.5M | 0.02% |
+80,951
| New | +$10.3M |
|
|
KBAL
807
DELISTED
Kimball International
KBAL
| $10.5M | 0.02% |
807,275
+122,068
| +18% | +$1.61M |
|
|
SDLP
808
DELISTED
SEADRILL PARTNERS LLC
SDLP
| $10.5M | 0.02% |
31,749
+1,868
| +6% | +$584K |
|
809
Hyatt Hotels
H
$16.9B
| $10.5M | 0.02% |
172,400
-206,000
| -54% | -$11.9M |
|
810
Mettler-Toledo International
MTD
$28.7B
| $10.5M | 0.02% |
41,400
-80,154
| -66% | -$19.3M |
|
|
BWP
811
DELISTED
Boardwalk Pipeline Partners
BWP
| $10.5M | 0.02% |
565,900
-397,835
| -41% | -$6.5M |
|
|
AGU
812
DELISTED
Agrium
AGU
| $10.4M | 0.02% |
114,000
+98,900
| +655% | +$9.17M |
|
|
CODE
813
DELISTED
SPANSION INC, CLASS A COMMON STOCK
CODE
| $10.4M | 0.02% |
495,210
+105,677
| +27% | +$2M |
|
814
Kirby Corp
KEX
$7.26B
| $10.4M | 0.02% |
+88,800
| New | +$9.53M |
|
|
ATHL
815
DELISTED
ATHLON ENERGY INC COM
ATHL
| $10.4M | 0.02% |
218,000
+2,199
| +1% | +$92.2K |
|
|
TRIB
816
Trinity Biotech
TRIB
$8.01M
| $10.4M | 0.02% |
3,007
+5
| +0.2% | +$17.8K |
|
817
SouthState Bank Corp
SSB
$10.8B
| $10.4M | 0.02% |
170,278
-7,771
| -4% | -$461K |
|
818
Southwest Gas
SWX
$6.67B
| $10.4M | 0.02% |
196,100
+190,558
| +3,438% | +$10.1M |
|
|
AD
819
Array Digital Infrastructure
AD
$3.09B
| $10.3M | 0.02% |
253,500
-85,845
| -25% | -$3.52M |
|
|
TIVO
820
DELISTED
TIVO INC
TIVO
| $10.3M | 0.02% |
800,295
-34,617
| -4% | -$420K |
|
821
Idacorp
IDA
$8.16B
| $10.3M | 0.02% |
+178,624
| New | +$9.87M |
|
822
Polaris
PII
$3.91B
| $10.3M | 0.02% |
+79,300
| New | +$10.5M |
|
|
RST
823
DELISTED
ROSETTA STONE INC
RST
| $10.3M | 0.02% |
1,061,300
-3,400
| -0.3% | -$35.5K |
|
|
CEB
824
DELISTED
CEB Inc.
CEB
| $10.3M | 0.02% |
150,993
+63,800
| +73% | +$4.38M |
|
|
RKT
825
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $10.3M | 0.02% |
+194,726
| New | +$9.81M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.